ONECUT2 is a novel target for treatment of castration-resistant prostate cancer

被引:4
作者
Joglekar, Tejashree [1 ,2 ]
Lin, Jianqing [2 ,3 ]
Shibata, Maho [1 ,2 ]
机构
[1] George Washington Univ, Sch Med & Hlth Sci, Dept Anat & Cell Biol, Washington, DC 20052 USA
[2] George Washington Univ, Sch Med & Hlth Sci, Canc Ctr, Washington, DC 20052 USA
[3] George Washington Univ, Sch Med & Hlth Sci, Dept Med, Div Hematol Oncol, Washington, DC 20052 USA
关键词
AR-independent prostate cancer; castration-resistant prostate cancer; neuroendocrine prostate cancer; ONECUT2; prostate cancer; MECHANISM;
D O I
10.1080/14728222.2020.1723080
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:89 / 90
页数:2
相关论文
共 10 条
  • [1] The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer
    Akamatsu, Shusuke
    Wyatt, Alexander W.
    Lin, Dong
    Lysakowski, Summer
    Zhang, Fan
    Kim, Soojin
    Tse, Charan
    Wang, Kendric
    Mo, Fan
    Haegert, Anne
    Brahmbhatt, Sonal
    Bell, Robert
    Adomat, Hans
    Kawai, Yoshihisa
    Xue, Hui
    Dong, Xin
    Fazli, Ladan
    Tsai, Harrison
    Lotan, Tamara L.
    Kossai, Myriam
    Mosquera, Juan Miguel
    Rubin, Mark A.
    Beltran, Himisha
    Zoubeidi, Amina
    Wang, Yuzhuo
    Gleave, Martin E.
    Collins, Colin C.
    [J]. CELL REPORTS, 2015, 12 (06): : 922 - 936
  • [2] Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer
    Aparicio, Ana M.
    Harzstark, Andrea L.
    Corn, Paul G.
    Wen, Sijin
    Araujo, John C.
    Tu, Shi-Ming
    Pagliaro, Lance C.
    Kim, Jeri
    Millikan, Randall E.
    Ryan, Charles
    Tannir, Nizar M.
    Zurita, Amado J.
    Mathew, Paul
    Arap, Wadih
    Troncoso, Patricia
    Thall, Peter F.
    Logothetis, Christopher J.
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (13) : 3621 - 3630
  • [3] Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
    Beltran, Himisha
    Prandi, Davide
    Mosquera, Juan Miguel
    Benelli, Matteo
    Puca, Loredana
    Cyrta, Joanna
    Marotz, Clarisse
    Giannopoulou, Eugenia
    Chakravarthi, Balabhadrapatruni V. S. K.
    Varambally, Sooryanarayana
    Tomlins, Scott A.
    Nanus, David M.
    Tagawa, Scott T.
    Van Allen, Eliezer M.
    Elemento, Olivier
    Sboner, Andrea
    Garraway, Levi A.
    Rubin, Mark A.
    Demichelis, Francesca
    [J]. NATURE MEDICINE, 2016, 22 (03) : 298 - 305
  • [4] Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling
    Bluemn, Eric G.
    Coleman, Ilsa M.
    Lucas, Jared M.
    Coleman, Roger T.
    Hernandez-Lopez, Susana
    Tharakan, Robin
    Bianchi-Frias, Daniella
    Dumpit, Ruth F.
    Kaipainen, Arja
    Corella, Alexandra N.
    Yang, Yu Chi
    Nyquist, Michael D.
    Mostaghel, Elahe
    Hsieh, Andrew C.
    Zhang, Xiaotun
    Corey, Eva
    Brown, Lisha G.
    Nguyen, Holly M.
    Pienta, Kenneth
    Ittmann, Michael
    Schweizer, Michael
    True, Lawrence D.
    Wise, David
    Rennie, Paul S.
    Vessella, Robert L.
    Morrissey, Colm
    Nelson, Peter S.
    [J]. CANCER CELL, 2017, 32 (04) : 474 - +
  • [5] ONECUT2 is a driver of neuroendocrine prostate cancer
    Guo, Haiyang
    Ci, Xinpei
    Ahmed, Musaddeque
    Hua, Junjie Tony
    Soares, Fraser
    Lin, Dong
    Puca, Loredana
    Vosoughi, Aram
    Xue, Hui
    Li, Estelle
    Su, Peiran
    Chen, Sujun
    Tran Nguyen
    Liang, Yi
    Zhang, Yuzhe
    Xu, Xin
    Xu, Jing
    Sheahan, Anjali V.
    Ba-Alawi, Wail
    Zhang, Si
    Mahamud, Osman
    Vellanki, Ravi N.
    Gleave, Martin
    Bristow, Robert G.
    Haibe-Kains, Benjamin
    Poirier, John T.
    Rudin, Charles M.
    Tsao, Ming-Sound
    Wouters, Bradly G.
    Fazli, Ladan
    Feng, Felix Y.
    Ellis, Leigh
    van der Kwast, Theo
    Berlin, Alejandro
    Koritzinsky, Marianne
    Boutros, Paul C.
    Zoubeidi, Amina
    Beltran, Himisha
    Wang, Yuzhuo
    He, Housheng Hansen
    [J]. NATURE COMMUNICATIONS, 2019, 10 (1)
  • [6] From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer
    Lapuk, Anna V.
    Wu, Chunxiao
    Wyatt, Alexander W.
    McPherson, Andrew
    McConeghy, Brian J.
    Brahmbhatt, Sonal
    Mo, Fan
    Zoubeidi, Amina
    Anderson, Shawn
    Bell, Robert H.
    Haegert, Anne
    Shukin, Robert
    Wang, Yuzhuo
    Fazli, Ladan
    Hurtado-Coll, Antonio
    Jones, Edward C.
    Hach, Faraz
    Hormozdiari, Fereydoun
    Hajirasouliha, Iman
    Boutros, Paul C.
    Bristow, Robert G.
    Zhao, Yongjun
    Marra, Marco A.
    Fanjul, Andrea
    Maher, Christopher A.
    Chinnaiyan, Arul M.
    Rubin, Mark A.
    Beltran, Himisha
    Sahinalp, S. Cenk
    Gleave, Martin E.
    Volik, Stanislav V.
    Collins, Colin C.
    [J]. JOURNAL OF PATHOLOGY, 2012, 227 (03) : 286 - 297
  • [7] Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
    Li, Qiuhui
    Deng, Qu
    Chao, Hsueh-Ping
    Liu, Xin
    Lu, Yue
    Lin, Kevin
    Liu, Bigang
    Tang, Gregory W.
    Zhang, Dingxiao
    Tracz, Amanda
    Jeter, Collene
    Rycaj, Kiera
    Calhoun-Davis, Tammy
    Huang, Jiaoti
    Rubin, Mark A.
    Beltran, Himisha
    Shen, Jianjun
    Chatta, Gurkamal
    Puzanov, Igor
    Mohler, James L.
    Wang, Jianmin
    Zhao, Ruizhe
    Kirk, Jason
    Chen, Xin
    Tang, Dean G.
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [8] ONECUT2 overexpression promotes RAS-driven lung adenocarcinoma progression
    Ma, Qingyang
    Wu, Kai
    Li, Hui
    Li, Huichun
    Zhu, Yufei
    Hu, Guohong
    Hu, Landian
    Kong, Xiangyin
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [9] ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis
    Rotinen, Mirja
    You, Sungyong
    Yang, Julie
    Coetzee, Simon G.
    Reis-Sobreiro, Mariana
    Huang, Wen-Chin
    Huang, Fangjin
    Pan, Xinlei
    Yanez, Alberto
    Hazelett, Dennis J.
    Chu, Chia-Yi
    Steadman, Kenneth
    Morrissey, Colm M.
    Nelson, Peter S.
    Corey, Eva
    Chung, Leland W. K.
    Freedland, Stephen J.
    Di Vizio, Dolores
    Garraway, Isla P.
    Murali, Ramachandran
    Knudsen, Beatrice S.
    Freeman, Michael R.
    [J]. NATURE MEDICINE, 2018, 24 (12) : 1887 - +
  • [10] Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
    Zou, Min
    Toivanen, Roxanne
    Mitrofanova, Antonina
    Floch, Nicolas
    Hayati, Sheida
    Sun, Yanping
    Le Magnen, Clementine
    Chester, Daniel
    Mostaghel, Elahe A.
    Califano, Andrea
    Rubin, Mark A.
    Shen, Michael M.
    Abate-Shen, Cory
    [J]. CANCER DISCOVERY, 2017, 7 (07) : 736 - 749